Key result
Homozygous PLN-R14del drives protein aggregation and proteostasis disruption prior to functional cardiac decline.
Why the study?
The PLN-R14del variant causes cardiomyopathy and heart failure, but the underlying pathophysiology is unknown and a suitable therapy is unavailable.
PLN protein aggregation and disrupted proteostasis are early, disease-specific drivers of PLN-R14del cardiomyopathy that precede functional decline, presenting potential targets for early intervention.
Early proteostasis disruption precedes dysfunction in PLN-R14del models; hypothesis-generating for targeted intervention but should not yet change practice.
Background: The p.(Arg14del) pathogenic variant (R14del) of the PLN (phospholamban) gene is a prevalent cause of cardiomyopathy with heart failure. The exact underlying pathophysiology is unknown, and a suitable therapy is unavailable. We aim to identify molecular perturbations underlying this cardiomyopathy in a clinically relevant PLN-R14del mouse model. Methods: We investigated the progression of cardiomyopathy in PLN-R14 Δ/Δ mice using echocardiography, ECG, and histological tissue analysis. RNA sequencing and mass spectrometry were performed on cardiac tissues at 3 (before the onset of disease), 5 (mild cardiomyopathy), and 8 (end stage) weeks of age. Data were compared with cardiac expression levels of mice that underwent myocardial ischemia-reperfusion or myocardial infarction surgery, in an effort to identify alterations that are specific to PLN-R14del–related cardiomyopathy. Results: At 3 weeks of age, PLN-R14 Δ/Δ mice had normal cardiac function, but from the age of 4 weeks, we observed increased myocardial fibrosis and impaired global longitudinal strain. From 5 weeks onward, ventricular dilatation, decreased contractility, and diminished ECG voltages were observed. PLN protein aggregation was present before onset of functional deficits. Transcriptomics and proteomics revealed differential regulation of processes involved in remodeling, inflammation, and metabolic dysfunction, in part, similar to ischemic heart disease. Altered protein homeostasis pathways were identified exclusively in PLN-R14 Δ/Δ mice, even before disease onset, in concert with aggregate formation. Conclusions: We mapped the development of PLN-R14del–related cardiomyopathy and identified alterations in proteostasis and PLN protein aggregation among the first manifestations of this disease, which could possibly be a novel target for therapy.
No takes yet. Share an insight, caveat, or question.
Eijgenraam et al. (2021) studied PLN-R14del-related cardiomyopathy. PLN-R14del pathogenic variant vs. Wild-type littermates and ischemic heart failure models was evaluated on Progression of cardiomyopathy characterized by echocardiography, ECG, histology, and omics. PLN-R14 Δ/Δ mice developed PLN protein aggregation and altered protein homeostasis before onset of structural and functional deficits, distinguishing this pathology from ischemic heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: